AARM 2024 Conference to Feature Dedicated Session on Autism and Cancer

We are pleased to announce a significant addition to the upcoming 1st International Conference on Autism Advanced Research and Management (AARM 2024). A dedicated session on “Preventing, Diagnosing, and Treating Cancer Among People with Autism: From the Bench and the Clinic to Public Health and Policy” will be featured, focusing on the intersection of these two critical areas of health and research.

This session will bring together leading experts in both fields to explore current trends and challenges at the nexus of autism and cancer. The discussion will center on ensuring equal opportunities for autistic individuals diagnosed with cancer, striving to overcome treatment barriers, and eliminating stigma associated with these conditions.

The goal of this session is not only to address these social and medical challenges but also to highlight pioneering research focusing on how cancer affects the autistic population differently. Our experts will delve into topics such as tailored treatment approaches, accessibility of cancer care, and the importance of inclusive health practices that consider the unique needs of autistic individuals.

This special session aims to foster a deeper understanding of both autism and cancer, encouraging a more inclusive and effective approach in medical research and treatment strategies.

• Round Table: “Preventing, Diagnosing, and Treating Cancer Among People with Autism: From the Bench and the Clinic to Public Health and Policy”
• Moderation: Dr. Christos Tsagkaris, Horizon Europe Cancer Mission Board, Brussels, Belgium

Panelists:

Dr. Andreas Koulouris, Karolinska University Hospital, Stockholm, Sweden

Topic: The Oncologist’s Viewpoint: Understanding and Treating Cancer in the Context of Autism Spectrum Disorders

Prof. Eleni (Lina) Tolma, University of Nicosia, Nicosia, Cyprus/Horizon Europe Cancer Mission Board, Brussels, Belgium

Topic: The Public Health Viewpoint: Health Promotion at the Intersection of Cancer and Neurodivergence

Dr. Yeva Margaryan, Institute of Cancer and Crisis, Yerevan, Armenia

Topic: The Syndemic Approach: Preventing and Treating Cancer in People with Neurodivergence in Crisis Settings

Dr. Christos Tsagkaris

Topic: The Health Policy Viewpoint: The Horizon Europe Cancer Mission and the European Approach Towards Quality of Life for Cancer Patients and Survivors

Join us in Athens from September 27-29, 2024, to be part of this vital conversation aimed at fostering a deeper understanding of both autism and cancer. This dialogue is essential for developing more inclusive and effective health solutions across diverse communities.

For the Scientific Committee of the Conference, Professor Athanasios Alexiou, General co-Chair.

For more information or to register for the conference, visit:

Conference website.

Conference registration.